346 related articles for article (PubMed ID: 18791417)
1. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
[TBL] [Abstract][Full Text] [Related]
2. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
[TBL] [Abstract][Full Text] [Related]
5. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
6. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.
Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K
Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550
[TBL] [Abstract][Full Text] [Related]
8. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
9. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
[TBL] [Abstract][Full Text] [Related]
10. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1H magnetic resonance spectroscopy.
Yu Q; Yang J; Wang P; Shi H; Luo J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):264-70. PubMed ID: 17630099
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.
Kolwijck E; Engelke UF; van der Graaf M; Heerschap A; Blom HJ; Hadfoune M; Buurman WA; Massuger LF; Wevers RA
NMR Biomed; 2009 Dec; 22(10):1093-9. PubMed ID: 19593761
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
13. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
Booth SJ; Pickles MD; Turnbull LW
BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
[TBL] [Abstract][Full Text] [Related]
14. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
[TBL] [Abstract][Full Text] [Related]
15. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
16. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
18. Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T.
King AD; Yeung DK; Ahuja AT; Yuen EH; Ho SF; Tse GM; van Hasselt AC
Clin Radiol; 2005 May; 60(5):592-8. PubMed ID: 15851048
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
20. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings--preliminary results.
Pinker K; Stavrou I; Szomolanyi P; Hoeftberger R; Weber M; Stadlbauer A; Noebauer-Huhmann IM; Knosp E; Trattnig S
Invest Radiol; 2007 Jun; 42(6):346-51. PubMed ID: 17507804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
